Patent Assignment
Reel/Frame 025728/0451
Assignment of Assignor's Interest
Recorded: 2011-02-01
Pages: 7
Assignor
LEAD THERAPEUTICS, INC.
Executed: 2010-11-23
Assignee
BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE, NOVATO, CALIFORNIA, 94949
Covered Properties
(5)
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) for Use in Treatment of Diseases Associated with a Pten Deficiency
Application:
61/301,174 →
5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
Application:
61/301,525 →
Processes of Synthesizing Dihydropyridophthalazinone Derivatives
Application:
61/302,457 →
Dihydropyridophthalazinone Inhibors of Poly(ADP-ribose)polymerase (PARP)
Application:
61/325,126 →
Novel Semi-Synthetic Glycopeptides as Antibacterial Agents
Application:
61/331,285 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 20, 2010
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0650 →
Assignment of Assignor's Interest
Oct 20, 2010
From: CHU, DANIEL; YE, TAO
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0835 →
Assignment of Assignor's Interest
Oct 20, 2010
From: WANG, BING
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0745 →
Assignment of Assignor's Interest
Oct 20, 2010
From: CHU, DANIEL; WANG, BING
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0523 →
Corrective Assignment to Correct the Missing Inventor Name Previously Recorded on Reel 025168 Frame 0745. Assignor(S) Hereby Confirms the Assignment.
Oct 26, 2010
From: WANG, BING; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025195/0130 →
Assignment of Assignor's Interest
Jan 10, 2011
From: CHU, DANIEL; WANG, BING; FENG, YING; SHEN, YUQIAO
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025774/0025 →
Assignment of Assignor's Interest
Jan 10, 2011
From: POST, LEONARD EDWIN
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025766/0081 →
Corrective Assignment to Correct the Missing Inventor Name and the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics, Inc. Previously Recorded on Reel 025168 Frame 0835. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2011
From: CHU, DANIEL; YE, TAO; WANG, BING
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025765/0706 →
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics, Inc. Previously Recorded on Reel 025168 Frame 0523. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2011
From: CHU, DANIEL; WANG, BING
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025620/0796 →
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics,Inc. Previously Recorded on Reel 025168 Frame 0650. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2011
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025764/0684 →
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics, Inc. Previously Recorded on Reel 025195 Frame 0130. Assignor(S) Hereby Confirms the Assignment.
Jan 25, 2011
From: WANG, BING; CHU, DANIEL
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025691/0346 →
Security Interest
Oct 23, 2015
From: MEDIVATION, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036866/0635 →
Assignment of Assignor's Interest
Mar 30, 2016
From: MEDIVATION, INC.
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 038138/0043 →
Assignment of Assignor's Interest
Mar 30, 2016
From: BIOMARIN PHARMACEUTICAL INC.
To: MEDIVATION, INC.
Reel/Frame 038137/0906 →
Release of Security Interest
Sep 28, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATION, INC.
Reel/Frame 039873/0219 →